Contact Information: Contact: Peretz Bronstein or Eitan Kimelman Bronstein, Gewirtz & Grossman, LLC 212-697-6484
Bronstein, Gewirtz & Grossman, LLC Announces Class Action Lawsuit Against Immucor, Inc.
| Source: Bronstein, Gewirtz & Grossman, LLC
NEW YORK, NY--(Marketwire - September 17, 2009) - Bronstein, Gewirtz & Grossman, LLC announces
that a class action has been filed in the United States District Court for
the Northern District of Georgia on behalf of those who purchased or
otherwise acquired stock of Immucor, Inc. ("Immucor" or the "Company")
(NASDAQ : BLUD ), during the period from October 19, 2005 through and
including April 23, 2009 (the "Class Period").
The Complaint charges that defendant violated the Securities and Exchange
Act of 1934 by failing to disclose that the Company was operating in
violation of the federal antitrust laws of the United States. Immucor
issued a press release on April 24, 2009, announcing that it had received a
subpoena from the United States Department of Justice, Antitrust Division,
pertaining to an investigation of possible violation of the federal
criminal antitrust laws in the blood reagents industry. On this news,
Immucor's stock price dropped from $20.98 on April 23, 2009 to $15.35 on
the next trading day.
No Class has yet been certified in the above action. If you wish to review
a copy of the Complaint, to discuss this action, or have any questions,
please contact either Peretz Bronstein or Eitan Kimelman of Bronstein,
Gewirtz & Grossman, LLC at 212-697-6484 or via email eitan@bgandg.com.
Those who inquire by e-mail are encouraged to include their mailing address
and telephone number. October 26, 2009 is the deadline for investors to
seek a lead plaintiff appointment.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our
primary expertise is the aggressive pursuit of litigation claims on behalf
of our clients. In addition to representing institutions and other
investor plaintiffs in class action security litigation, the firm's
expertise includes general corporate work, private securities offerings,
and securities arbitration.